XERS Q1 2020 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena

XERSXeris Biopharma Holdings, Inc.

$982M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+621.0% YoY

Gross Profit

-$2,000-0.1% margin

Operating Income

-$28M-1580.2% margin

Net Income

-$29M-1632.2% margin

EPS (Diluted)

$-0.89

QoQ Revenue Growth

-4.1%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$116M

Total Liabilities

$89M

Stockholders' Equity

$27M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$248,000	+621.0%
Gross Profit	-$2,000	$248,000	-100.8%
Operating Income	-$28M	-$25M	-11.1%
Net Income	-$29M	-$25M	-15.5%